Friday's Analysts' Upgrades and Downgrades

Goldman is upping its target on Celgene(CELG Quote) to $59 from $50 based on expectations for $1.43 of EPS in 2008. 2007 estimates lowered 5 cents to $0.91 due to higher expenses. Maintained Neutral rating.

Target on Clorox(CLX Quote) increased to $71 from $68 at Goldman. Solid second-quarter results result in 2007 estimates moving up a penny to $3.21. Maintained Neutral rating.

2007 estimates on Comcast(CMCSA Quote) cut to $1.10 from $1.40 at Goldman. Higher-than-expected revenue, EBITDA, and RGU guidance offset by capital expenditures and resulting in lower free cash flow. Maintained Buy rating and $51 target.

Cognizant Technology(CTSH Quote) numbers raised at Jefferies. Price target jumps to $100 from $86, and 2008 EPS estimates initiated at $2.84. Reiterates Buy rating.

Intuitive Surgical(ISRG Quote) numbers raised at Jefferies. Price target lifts to $108 from $100, and 2007 EPS estimates rise to $3.03 from $2.74. Reiterates Hold rating.

Millipore(MIL Quote) numbers raised at UBS. Price target lifts to $85 from $80, and 2007 EPS estimates rise to $3.40 from $3.30. Reiterates Buy rating.

Credit Suisse is lowering its 2007 EPS estimates on Under Armour(UA Quote) by 5 cents to $1.00 following slight miss in Q4 results. Maintained $65 target price.

Goldman is raising its 2007 estimates on Valero to $8.32 from $7.90 following standout fourth-quarter earnings. Management focusing strategy on improving profitability vs. other refiners and returning excess cash to shareholders. Price target increased to $60 from $58 and maintained Neutral rating.